GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC16517 structure
    GC16517Eugenol
    CAS: 97-53-0
    Purity: >98.00%

    الأوجينول هو زيت أساسي موجود في القرنفل مع نشاط مضاد للبكتيريا وطارد للديدان ومضاد للأكسدة

  • GC16536 structure
    GC16536Phenyl sulfate
    CAS: 937-34-8
    Purity: >99.50%

    A neuropeptide with diverse biological activities

  • GC16538 structure
    GC16538RWJ 21757
    CAS: 121288-39-9
    Purity: >98%

    RWJ 21757 (7-Allyl-8-oxoguanosine) هو نظير غوانوزين مع أنشطة مضادة للفيروسات ومضادة للأورام.

  • GC16656 structure
    GC16656L-Canavanine sulfate
    CAS: 2219-31-0
    Purity: >97.00%

    L-Canavanine sulfate هو مثبط انتقائي لـ NO synthase المحرض

  • GC16657 structure
    GC16657PPM-18
    CAS: 65240-86-0
    Purity: >98%

    NF-κB inhibitor

  • GC16658 structure
    GC16658Vinpocetine
    CAS: 42971-09-5
    Purity: >99.50%

    Vinpocetine (Ethyl apovincaminate) هو مشتق من قلويد الفينكامين الذي يحجب قنوات Na + ذات الجهد الكهربائي

  • GC16664 structure
    GC166642-Iminobiotin
    CAS: 13395-35-2
    Purity: >98.00%

    2-Iminobiotin (Guanidinobiotin) هو البيوتين (فيتامين H أو B7) التناظرية

  • GC16795 structure
    GC16795DCA
    CAS: 2156-56-1
    Purity: >98.00%

    DCA هو مُنظم للأيض في ميتوكوندريا خلايا السرطان وله نشاط مضاد للسرطان. يعمل DCA على تثبيط PDHK، مما يؤدي إلى انخفاض حامض اللاكتيك في بيئة الورم. كما يزيد DCA من إنتاج جزيئات الأكسجة المتفاعلة (ROS) ويلعب دورًا في تحفيز خلايا السرطان على التصَّاب. كذلك، يعمل DCA كمثبِّط NKCC.

  • GC16831 structure
    GC16831Agmatine sulfate
    CAS: 2482-00-0
    Purity: >98.00%

    تمارس كبريتات أغماتين إجراءات تعديل في أهداف جزيئية متعددة ، مثل أنظمة الناقلات العصبية والقنوات الأيونية وتوليف أكسيد النيتريك

  • GC16832 structure
    GC16832Suramin hexasodium salt
    CAS: 129-46-4
    Purity: >98.00%

    ملح سداسي الصوديوم سورامين (سورامين ملح سداسي الصوديوم) هو مثبط تنافسي للبروتين التيروزين الفوسفاتيز (PTPases).

  • GC16868 structure
    GC16868Sulfasalazine
    CAS: 599-79-1
    Purity: >98.00%

    سلفاسالازين (NSC 667219) هو عامل مضاد للروماتيزم لأبحاث التهاب المفاصل الروماتويدي والتهاب القولون التقرحي

  • GC16874 structure
    GC16874Ro 106-9920
    CAS: 62645-28-7
    Purity: >98%

    Ro 106-9920 هو مثبط قوي لـ NF-kappaBRo 106-9920 لديه القدرة على البحث في أمراض الأورام والسرطان

  • GC16889 structure
    GC16889Nisoldipine
    CAS: 63675-72-9
    Purity: >99.00%

    Nisoldipine (BAY-k 5552 ؛ Sular) هو مانع لقنوات الكالسيوم ينتمي إلى فئة dihydropyridines ، خاصة بـ L-type Cav1.2 مع IC50 من 10 نانومتر

  • GC16921 structure
    GC16921Bromhexine HCl
    CAS: 611-75-6
    Purity: >99.00%

    Bromhexine HCl هو مثبط بروتياز TMPRSS2 قوي ومحدد مع IC50 من 0.75 μ ؛ M.

  • GC16926 structure
    GC16926L-NMMA acetate
    CAS: 53308-83-1
    Purity: >98.00%

    أسيتات L-NMMA هو مثبط سينثاز أكسيد النيتريك لجميع الأشكال الإسوية NOS بما في ذلك NOS1 و NOS2 و NOS3

  • GC17043 structure
    GC17043StemRegenin 1 (SR1)
    CAS: 1227633-49-9
    Purity: >98.00%

    StemRegenin 1 (SR1) is a potent aromatic hydrocarbon receptor (AhR) antagonist (IC 50 = 127nM).

  • GC17084 structure
    GC170842-Imino-4-methylpiperidine (acetate)
    CAS: 165383-72-2
    Purity: >98%

    2-Imino-4-methylpiperidine (acetate) هو مثبط فعال وفعال عن طريق الفم NO synthase (NOS) مع IC50s من 0.1 μ ؛ M ، 1.1 μ ؛ M ، و 0.2 μ ؛ M لـ iNOS البشري (hiNOS) ، heNOS hnNOS ، على التوالي.

  • GC17129 structure
    GC17129W 54011
    CAS: 405098-33-1
    Purity: >98.00%

    يعتبر W 54011 أحد مضادات مستقبلات C5a غير الببتيدية الفعالة عن طريق الفم.

  • GC17136 structure
    GC17136MRT67307
    CAS: 1190378-57-4
    Purity: >98.50%

    A kinase inhibitor

  • GC17237 structure
    GC17237NG,NG-dimethyl-L-Arginine (hydrochloride)
    CAS: 220805-22-1
    Purity: >95.00%

    endogenous nitric oxide synthase inhibitor

  • GC17255 structure
    GC17255Gliotoxin
    CAS: 67-99-2
    Purity: >98.00%

    Gliotoxin, an immunosuppressive mycotoxin produced by pathogenic strains of Aspergillus and other fungi, is a specific inhibitor of 20S proteasomal chymotrypsin activity with an IC 50 of 10μM.

  • GC17263 structure
    GC17263Leukadherin 1
    CAS: 344897-95-6
    Purity: >98.00%

    Leukadherin 1 ، ناهض محدد لسطح كريات الدم البيضاء إنتغرين CD11b / CD18 ، يزيد من التصاق الخلية المعتمدة على CD11b / CD18 بالفيبرينوجين مع EC50 من 4 ميكرومتر.

  • GC17279 structure
    GC17279N-3-oxo-dodecanoyl-L-Homoserine lactone
    CAS: 168982-69-2
    Purity: >97.00%

    N-3-oxo-dodecanoyl-L-Homoserine lactone (3-oxo-C12-HSL), as a quorum-sensing (QS) molecule produced by Gram-negative bacteria in the gastrointestinal tract, is a major inducer of oxidative stress indicated by a high level of intracellular reactive oxygen species (ROS).

  • GC17309 structure
    GC17309Withaferin A
    CAS: 5119-48-2
    Purity: >98.00%

    Withaferin A هو لاكتون ستيرويدي معزول من Withania somnifera ، يمنع تنشيط NF-kB ويستهدف الفيمنتين ، مع أنشطة قوية مضادة للالتهابات ومضادة للسرطان